Israel

Surprising many industry observers, BMI included, on May 28 Israel's Taro Pharmaceutical Industries terminated its proposed merger with India's Sun Pharmaceutical Industries, bringing... 2008-05-29

In terms of volume, the Office of the US Trade Representative (USTR)'s 2008 Special 301 Report suggests that BMI's belief that this year will see the US push to improve intellectual... 2008-05-01

A poll by Israeli research institute Geocartography Knowledge Group (GCKG) into citizens' views on the country's healthcare system has found substantial opposition to the gradual... 2008-03-14

In a move that BMI interprets as a signal that India's Sun Pharmaceutical Industries is growing impatient with opposition to its proposed acquisition of Israel's Taro Pharmaceutical... 2008-02-25

On February 21, the world's largest generics company, Israel's Teva Pharmaceutical Industries held its investor day in New York - an event monitored by BMI's pharma team. Teva outlined... 2008-02-22

An appreciating exchange rate has prompted the Ministry of Health to make cuts to the maximum price of prescription medicines that can be charged by pharmacies and health funds in... 2008-02-21

Opposition from leading generic drugmakers, principally Teva Pharmaceutical Industries, has put into doubt government plans to improve Israel's intellectual property (IP) environment... 2007-12-14

Israel's Teva Pharmaceutical Industries has joined a line of research-focused multinationals in posting disappointing Q307 results. While research-focused drugmakers have blamed falling... 2007-11-05

Israel's BioLineRX is investigating the possibility of a listing on the US NASDAQ as the clinical research firm considers how to raise capital for its R&D activities. BioLineRX... 2007-10-23

Israel's generics heavyweight Teva Pharmaceutical Industries has announced it is to invest a massive US$149mn in its local facilities over the next three years. The majority of the... 2007-10-17